Top compounds associated with response to PARVG


Feature Type Standardized
Nominal ANOVA
mRNA ATRA CTRPv2 pan-cancer AAC 0.32 2e-17
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.32 7e-16
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.31 4e-15
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 8e-14
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.28 1e-13
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 2e-12
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 5e-12
mRNA linifanib GDSC1000 pan-cancer AAC 0.29 9e-12
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.27 1e-11
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.25 3e-11
Download CSV